ERBB2 and neoplasm: The killing of MCF-7 tumor spheroids was augmented by the presence of the Trastuzumab and NK92-CD16 cells, presumably due to HER2 antibody-dependent NK cell-mediated cytotoxicity (Fig. 7a, b).